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vo2max (16.3t-0.7 vs 18.7t-0.8 ml/kg/min, p<0.001). Good correlations were found 
between training-induced increase in VO2max end training-induced reduction in levels of 
proinflammatory cytokine TNF-a (r=-0.54, p<0.01 ) and apoptosis inducer sFasL (r=-0.57, 
p<0.0O5) in CHF patients. On the contrary, no significant difference in circulating cytok- 
ines and apoptotic markers was found with physical training in normal subjects. 
Conclusions: Physical training reduces plasma levels of proinflammatory cytokines and 
sFas/sFasL system in patients with CHF. These immunomodulatory effects may be 
related to the training-induced improvement in functional status of CHF patients. 
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Background: The oxygen uptake efficiency slope, defined as VO2/Iog(VE), has been 
proposed as an effort-independent measure of cardiovascular fitness. The prognostic 
value of oxygen efficiency as compared to maximum VO2 has not been assessed. 
Methods: We followed 1661 consecutive patients with chronic heart failure who were 
referred for metabolic stress testing for heart transplant evaluation. Patients were fol- 
lowed for a median of 2 years (range 0-5 years). Patients who had transplantation 
(n=t 90) were censored. 
Results: Quartile values of oxygen efficiency were 0.98+0.15, 1.31_+0.08, 1.60+0.10, 
and 2.12+0.33. Compared to patients in the highest quartile, those in the lowest quartile 
had a lower peak VO2 (10.5 vs. 23.7 ml/kg/min), were older (57 VS, 48 years), and were 
more likely to have coronary disease (54% vs. 27%). There was a strong association 
between lower oxygen efficiency and mortality (Figure) 
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(unadjusted hazard ratio [HR] of lowest to highest quartile 6.5, 95% CI 4.5 to 9.3, 
P<0.0001). In a Cox regression analysis that accounted for demographics, coronary dis- 
ease, VENcc 2 slope, and other potential confounders, oxygen efficiency was an inde- 
pendent predictor of death (adjusted HR of lowest to highest quartile 4.1, 95% CI 2.6 to 
6.5, P<0.0001), whereas maximum Vo2 was no longer predictive (adjusted HR of lowest 
to highest quartile of Vo2 1.2, 95% CI 0.5 to 3.0).Conclusion: The oxygen uptake effi- 
ciency slope is a strong and independent predictor of mortality in patients with chronic 
heart failure. 
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Background: Although chronic beta-blockade has been shown to improve resting car- 
diac function in heart failure patients, there are minimal improvements in exercise capac- 
ity as measured by peak oxygen consumption. (PeakVO2) Recently, the ventilatory 
response to exercise, VE/VCO2, has been shown to have prognostic value in heart failure 
patients. The effect of beta-blockade on the ventilatory response to exercise is unknown. 
Methods: 26 patients with non-ischernic cardiomyopathy underwent cardiopulmonary 
exercise testing prior to and after six months of treatment with either placebo or beta- 
blockade (carvedilol or metoprolol). Peak exercise head rate, VO 2, and VENCO 2 were 
compared to baseline in each treatment group. 
Results: 
Placebo (pre) Placebo (post) Beta-Blocker (pre) Beta-Blocker (post) 
LVEF, % 24±2 28+4 20:~. 35_+2* 
Peak H R. bpm 145+4 144+~ 145:t:5 114_+4* 
Peak VO2 ml/kg/m 17.2_+1.6 16.8+1.9 15.4-+1.0 15.7±1.0 
Peak VENCO2 42.2:-+2.8 41.0+3.9 45.8+~.2 40.4_+1.5* 
(* p < 0,05) 
Conclusion: Chronic beta-blocker therapy results Jn a reduction in the excess ventilation 
with exercise in heart failure patients This reduction in VE/VCO 2 may have a favorable 
effect on both prognosis and functional capacity in heart failure patients. 
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Background. Although exercise training improves prognosis of ischemic heart failure, 
the effects on nonischemic heart failure are still unclear even in animal models. Because 
of metabolic bulnerability to sympathetic stimulation of failing heeds, exercise training 
may adversely affect the prognosis of nonischemic heart failure despite the beneficial 
effects on exercise capacity. To test the hypothesis, we examined the effect of exercise 
training with or without beta-blocker therapy on exercise capacity and prognosis of cardi- 
omyopathic hamsters. Methods. We assigned 87 BIO14.6 hamsters at 30 weeks of age 
into 3 groups; sedentary control group (group C, n=27 ), exercise training group ( group 
Ex, n=30 ), and exercise training plus beta-biockar group (group ExB, n=29 ). On Day 1 
of the study, baseline treadmill exercise was performed to determine the maximal run- 
ning speed at which animals could catch up. On Day 2, exercise training and medication 
were started. Treadmill exercise for 25 rain at 50% of the baseline maximal speed was 
performed on every week days for 160 days in groups Ex and ExB. In group ExB, meto- 
proiol of lmg/kg/day, a cardioselective betal-blocker, was orally administered during the 
study. To assess exercise capacity, the maximal treadmill exercise was performed on 
Day 30 and Day 90. The survival rate was assessed. Results. The maximal treadmill 
speed gradually decreased in groups C and ExB. However, the initial decrease on Day 
30 was not observed in group Ex, suggesting a short-term benefits of exercise training on 
exercise capacity. In contrast, the survival rate was lower throughout the study in group 
Ex than in group C (Kaplan-Meier, p<.005). This effect was partly but significantly attenu- 
ated in group ExB (p<.005). The survival rate on Day 160 was 70% in group C, 48% in 
group ExB, and only 33% in group Ex. Conclusion, Despite short-tarm benefits on exer- 
cise capacity, exercise training aggravated prognosis of cardiomyopathic hamsters. This 
effect was attenuated by cardioselective betal-blockade. Our results suggest that tong- 
term exercise training promotes the progression of cardiomyopathy via Betal-adrenergic 
stimulation. 
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Background: Plasma levels of brain natriuretic peptide (BNP) are elevated in patients 
(pts) with chronic heart failure subject to the degree of systolic and diastolic left ventricu- 
lar dysfunction. Whether BNP levels are likewise associated with exercise capacity in pts 
with CHF is unknown. 
Methods: 70 consecutive pts with CHF (60 :I: 10 years, 19 women, LVEF 26 + 4 %) and 
10 healthy controls (55 + 16 years, 4 women, LVEF 59 + 5 %) referred for cardiopulmo- 
nary exercise testing (CPX) were prospectively studied. Resting BNP (pg/ml; immunoas- 
say, Biosite Diagnostics, San Diego, USA) was obtained after 10 minutes of supine rest 
prior to symptom-limited bicycle exercise CPX. 
Results: BNP concentrations were significantly higher in pts with CHF than in controls 
(427.6 + 377.6 vs. 24.8 + 22.1 pg/ml, p < 0.0001). In CHF pts BNP levels strongly corre- 
lated with oxygen uptake, both at anaerobic threshold (VO2AT: r = -0.54, p < 0.001) and 
maximum exercise (VO2max: r = -0.56, p < 0.001). Impairment of ventilatory efficiency 
(EqCO2: r = 0.43, p < 0.001) and maximum exercise level (watts % predicted : r = -0.44, 
p < 0.05) correlated less well with BNP. There was a significant inverse correlation 
between LVEF and BNP (r = -0.50, p < 0.05). BNP discriminated well pts with a VO2max 
< 11 ml/min/kg (Area under the ROC 0.80 + 0.09) with a criterion value of 470 pg/mL BNP 
levels > 470 pg/ml were significantly associated with VO2max < 11 ml/min/kg (risk ratio 
13.1 [95%CI 2.5-69.2]) 
Conclusions: BNP is clearly associated with exercise capacity in CHF. BNP levels show 
a significant correlation with the impairment of ventilatory efficiency and oxygen uptake at 
maximum exercise and anaerobic threshold. BNP is able to discriminate between CHF 
pts with moderately or severely impaired exercise capacity. 
